TEAMLEASE.NSE

TeamLease Services Ltd

Workforce in India can rise 4.7% in April-Sept 2026 period, says HR firm report The hiring scenario in India is going to look up in the first six months of the next financial year. HR firm TeamLease Services has said that the sectors that are going to add energy to the hiring canvas of the country are e-commerce, tech startups, healthcare, pharma and manufacturing.

Mumbai: India's workforce is projected to expand 4.7 per cent in the first half of FY27, driven largely by growth in e-commerce, tech startups, healthcare, pharma and manufacturing, a report said Wednesday. This improving sentiment is most visible among large enterprises, where 74 per cent indicate expansion, compared to 57 per cent of mid-sized firms and 38 per cent of small businesses, pointing to a scale-driven recovery in employment growth, TeamLease Services projects in its Employment Outlook Report (EOR) for April- September FY27 noted that the momentum carries across sectors, with both digital and core economy industries contributing to the demand. E-commerce and tech startups led with a net employment change (NEC) of 8.9 per cent, healthcare, and pharmaceuticals at 7 per cent, followed by manufacturing, engineering and infrastructure at 6.6 per cent, said the report. It projected an NEC of 4.7 per cent during the period. The report is based on insights from 1,268 employers across 23 industries and 20 cities and was conducted between November 2025 and January 2026. "India's workforce dynamics are increasingly shaped by structural and policy-led shifts rather than cyclical demand.

Mumbai: India's workforce is projected to expand 4.7 per cent in the first half of FY27, driven largely by growth in e-commerce, tech startups, healthcare, pharma and manufacturing, a report said Wednesday. This improving sentiment is most visible among large enterprises, where 74 per cent indicate expansion, compared to 57 per cent of mid-sized firms and 38 per cent of small businesses, pointing to a scale-driven recovery in employment growth, TeamLease Services projects in its Employment Outlook Report (EOR) for April- September FY27 noted that the momentum carries across sectors, with both digital and core economy industries contributing to the demand. E-commerce and tech startups led with a net employment change (NEC) of 8.9 per cent, healthcare, and pharmaceuticals at 7 per cent, followed by manufacturing, engineering and infrastructure at 6.6 per cent, said the report. It projected an NEC of 4.7 per cent during the period. The report is based on insights from 1,268 employers across 23 industries and 20 cities and was conducted between November 2025 and January 2026. "India's workforce dynamics are increasingly shaped by structural and policy-led shifts rather than cyclical demand.

MUMBAI, India , Feb. 9, 2026 /PRNewswire/ -- Made in India , written by Sundeep Khanna and Manish Sabharwal, traces three remarkable journeys: the rise of India's pharma industry, the birth and evolution of Lupin (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) and the extraordinary life of its founder, Desh Bandhu Gupta. Together, the three journeys illuminate how a country once completely dependent on imported medicines became the world's pharmacy. The book shares how an individual's life, shaped early by adversity, growing up without privilege or patronage, unpredictably nurtured hunger and drive, to navigate an unforgiving state, blend national health priorities and global standards, to build a multibillion-dollar enterprise whose medicines reach patients in over 120 countries. (L to R) - Dilip Shanghvi, Sun Pharma; Dr. Yusuf Hamied, Cipla; G.V. Prasad, Dr. Reddy’s; Prof. M. M. Sharma, Ex-(UDCT) ICT; Vinita Gupta, Lupin; Moderator, Manish Sabharwal. Made in India shows the distance travelled by a village boy from Rajasthan, who went on to become a teacher, professor and pharmaceutical employee, before founding a company worth $10 billion.

MUMBAI, India , Feb. 9, 2026 /PRNewswire/ -- Made in India , written by Sundeep Khanna and Manish Sabharwal, traces three remarkable journeys: the rise of India's pharma industry, the birth and evolution of Lupin (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) and the extraordinary life of its founder, Desh Bandhu Gupta. Together, the three journeys illuminate how a country once completely dependent on imported medicines became the world's pharmacy. The book shares how an individual's life, shaped early by adversity, growing up without privilege or patronage, unpredictably nurtured hunger and drive, to navigate an unforgiving state, blend national health priorities and global standards, to build a multibillion-dollar enterprise whose medicines reach patients in over 120 countries. (L to R) - Dilip Shanghvi, Sun Pharma; Dr. Yusuf Hamied, Cipla; G.V. Prasad, Dr. Reddy’s; Prof. M. M. Sharma, Ex-(UDCT) ICT; Vinita Gupta, Lupin; Moderator, Manish Sabharwal. Made in India shows the distance travelled by a village boy from Rajasthan, who went on to become a teacher, professor and pharmaceutical employee, before founding a company worth $10 billion.

In this briefing: Aequitas: SAEL Industries Pre-IPO - Scalable Growth Amid Profitability Headwinds Aequitas: Fractal Analytics IPO - Margins Recovery With An Expensive Price Tag HSIE Results Daily: Bajaj Finance, Aditya Birla Capital, Mankind Pharma... HSIE Results Daily: Trent, Kansai Nerolac, JK Lakshmi Cement, Teamlease Services The Somewhat Boring Income Episode 1. Aequitas: SAEL Industries Pre-IPO - Scalable Growth Amid Profitability Headwinds SAEL Industries Ltd (2600245D IN) is looking to raise about US$516m in its upcoming India IPO. SAEL is a vertically integrated renewable energy independent power producer in India, with capabilities spanning solar module manufacturing, engineering, procurement and construction, and operations and maintenance for power projects. In this note, we talk about the company’s historical performance. 2. Aequitas: Fractal Analytics IPO - Margins Recovery With An Expensive Price Tag Fractal Analytics Ltd (2453623D IN) is looking to raise up to US$315m in its upcoming India IPO.

In this briefing: Aequitas: SAEL Industries Pre-IPO - Scalable Growth Amid Profitability Headwinds Aequitas: Fractal Analytics IPO - Margins Recovery With An Expensive Price Tag HSIE Results Daily: Bajaj Finance, Aditya Birla Capital, Mankind Pharma... HSIE Results Daily: Trent, Kansai Nerolac, JK Lakshmi Cement, Teamlease Services The Somewhat Boring Income Episode 1. Aequitas: SAEL Industries Pre-IPO - Scalable Growth Amid Profitability Headwinds SAEL Industries Ltd (2600245D IN) is looking to raise about US$516m in its upcoming India IPO. SAEL is a vertically integrated renewable energy independent power producer in India, with capabilities spanning solar module manufacturing, engineering, procurement and construction, and operations and maintenance for power projects. In this note, we talk about the company’s historical performance. 2. Aequitas: Fractal Analytics IPO - Margins Recovery With An Expensive Price Tag Fractal Analytics Ltd (2453623D IN) is looking to raise up to US$315m in its upcoming India IPO.

In this briefing: Aequitas: Fractal Analytics IPO - Margins Recovery With An Expensive Price Tag HSIE Results Daily: Bajaj Finance, Aditya Birla Capital, Mankind Pharma... HSIE Results Daily: Trent, Kansai Nerolac, JK Lakshmi Cement, Teamlease Services The Somewhat Boring Income Episode Alphabet (GOOG US) - AI Continues to Drive Strong Search and Cloud Business Performance 1. Aequitas: Fractal Analytics IPO - Margins Recovery With An Expensive Price Tag Fractal Analytics Ltd (2453623D IN) is looking to raise up to US$315m in its upcoming India IPO. Fractal Analytics Limited (FAL) is an enterprise artificial intelligence company which supports large global enterprises with data-driven insights and assists them in their decision making through its end-to-end AI solutions. We have looked at the company's past performance in our previous note. In this note, we talk about valuations. 2. HSIE Results Daily: Bajaj Finance, Aditya Birla Capital, Mankind Pharma... Bajaj Finance: Bajaj Finance’s (BAF) Q3FY26 PAT declined by 6% YoY due to accelerated provisioning of INR 14bn (0.3% of gross advances), given the implementation of minimum LGD floor across businesses Adjusted for this one-off, operating performance remained steady with AUM growth of 22% YoY, steady NIMs (~9%), marginal normalization in credit costs (1.92%), and robust profitability (RoE of 19.7%) Management has indicated improvement in credit costs during FY27 to sub-1.8%, along with pick-up in the MSME segment Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

In this briefing: Aequitas: Fractal Analytics IPO - Margins Recovery With An Expensive Price Tag HSIE Results Daily: Bajaj Finance, Aditya Birla Capital, Mankind Pharma... HSIE Results Daily: Trent, Kansai Nerolac, JK Lakshmi Cement, Teamlease Services The Somewhat Boring Income Episode Alphabet (GOOG US) - AI Continues to Drive Strong Search and Cloud Business Performance 1. Aequitas: Fractal Analytics IPO - Margins Recovery With An Expensive Price Tag Fractal Analytics Ltd (2453623D IN) is looking to raise up to US$315m in its upcoming India IPO. Fractal Analytics Limited (FAL) is an enterprise artificial intelligence company which supports large global enterprises with data-driven insights and assists them in their decision making through its end-to-end AI solutions. We have looked at the company's past performance in our previous note. In this note, we talk about valuations. 2. HSIE Results Daily: Bajaj Finance, Aditya Birla Capital, Mankind Pharma... Bajaj Finance: Bajaj Finance’s (BAF) Q3FY26 PAT declined by 6% YoY due to accelerated provisioning of INR 14bn (0.3% of gross advances), given the implementation of minimum LGD floor across businesses Adjusted for this one-off, operating performance remained steady with AUM growth of 22% YoY, steady NIMs (~9%), marginal normalization in credit costs (1.92%), and robust profitability (RoE of 19.7%) Management has indicated improvement in credit costs during FY27 to sub-1.8%, along with pick-up in the MSME segment Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.